List of SBIR/STTR awards granted to Via Therapeutics, LLC
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Via Therapeutics, LLC in September, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AR074360-01 | Phase I | 225,000 | September 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Via Therapeutics, LLC in March, 2021 for $256,350.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI162348-01 | Phase I | 256,350 | March 1, 2021 | |||||||
A SBIR Phase I contract was awarded to Via Therapeutics, LLC in July, 2021 for $251,917.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA257783-01A1 | Phase I | 251,917 | July 12, 2021 | |||||||
A STTR Phase I contract was awarded to Via Therapeutics, LLC in August, 2020 for $263,895.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41CA243931-01A1 | Phase I | 263,895 | August 1, 2020 | |||||||
A SBIR Phase II contract was awarded to Via Therapeutics, LLC for $2,999,221.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 272201800039C | Phase II | 2,999,221 | ||||||||
A SBIR Phase I contract was awarded to Via Therapeutics, LLC for $599,924.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 272201800039C-0-0-0 | Phase I | 599,924 | ||||||||
A SBIR Phase I contract was awarded to Via Therapeutics, LLC for $299,995.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93021C00042 | Phase I | 299,995 | ||||||||
A SBIR Phase II contract was awarded to Via Therapeutics, LLC for $1,468,122.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93023C00060 | Phase II | 1,468,122 |
